Trump pushes for enhanced transparency in pharmaceutical industry advertising

In a significant shift in policy, President Donald Trump has tasked the FDA with heightening the scrutiny of direct-to-consumer prescription drug ads, as the Epoch Times reports. President Trump’s directive to the FDA aims to enhance the transparency and accuracy of prescription drug advertising, ensuring full disclosure of risks. Since 1962, the FDA has been overseeing direct-to-consumer…

About The Author


Discover more from MEK Enterprises Blog - Breaking News, SEO, Information, and Making Money Online!

Subscribe to get the latest posts sent to your email.

Leave a Reply